Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BeOne Medicines Ltd.ONC · Entity 2168 | Chief Financial Officer | August 03, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BeOne Medicines Ltd.
Report date August 03, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-08-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-08-03 · Sale · Disposed 1,157 · Balance 0 F1: Each American Depositary Share represents 13 Ordinary Shares. F2: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 382,850 |
Reported balance
Holding disclosure · report date 2026-08-03 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 382,850 |
Filing footnotes · ownership attribution and instrument terms
F1: Each American Depositary Share represents 13 Ordinary Shares.
F2: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 5, 2026 21:15 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,157 | $312.72 | $361,811.26 |
DisclosureSEC source: 0002031182-26-000005 · wk-form4_1785964555.xml · nonDerivative · entry 2 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:55 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 137,865 | $0.00 Strike: $20.81 | $0.00 |
DisclosureSEC source: 0002031182-26-000003 · wk-form4_1781560521.xml · derivative · entry 3 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,865 Underlying: Ordinary Shares · 137,865 shares Expires 2036-06-10 F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F5 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:55 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 631 | $257.74 | $162,636.53 |
DisclosureSEC source: 0002031182-26-000003 · wk-form4_1781560521.xml · nonDerivative · entry 2 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.3392 to $257.765, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:55 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 71,175 | $0.00 | $0.00 |
DisclosureSEC source: 0002031182-26-000003 · wk-form4_1781560521.xml · nonDerivative · entry 1 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 397,891 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| March 06, 2026 Filed Mar 11, 2026 00:11 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 40,573 | $0.00 | $0.00 |
DisclosureSEC source: 0002031182-26-000002 · wk-form4_1773187889.xml · nonDerivative · entry 2 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,919 F2 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2028, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| March 06, 2026 Filed Mar 11, 2026 00:11 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 79,014 | $0.00 | $0.00 |
DisclosureSEC source: 0002031182-26-000002 · wk-form4_1773187889.xml · nonDerivative · entry 1 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,346 F1 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 21:16 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,190 | $290.47 | $345,659.30 |
DisclosureSEC source: 0001651308-25-000125 · wk-form4_1754428564.xml · nonDerivative · entry 2 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 21:45 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 119,873 | $0.00 Strike: $20.26 | $0.00 |
DisclosureSEC source: 0001651308-25-000108 · wk-form4_1749764747.xml · derivative · entry 2 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,873 Underlying: Ordinary Shares · 119,873 shares Expires 2035-06-09 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 21:45 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 63,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-25-000108 · wk-form4_1749764747.xml · nonDerivative · entry 1 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,802 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| March 05, 2025 Filed Mar 8, 2025 00:19 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 48,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-25-000043 · wk-form4_1741393174.xml · nonDerivative · entry 1 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,128 F1 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 21:17 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 220,987 | $0.00 Strike: $14.06 | $0.00 |
DisclosureSEC source: 0001651308-24-000100 · wk-form4_1723583832.xml · derivative · entry 2 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,987 Underlying: Ordinary Shares · 220,987 shares Expires 2034-08-08 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of July 31, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 21:17 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 118,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-24-000100 · wk-form4_1723583832.xml · nonDerivative · entry 1 Rosenberg Aaron · CIK 0002031182 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,547 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.